Form 8-K - Current report:
SEC Accession No. 0001193125-25-133348
Filing Date
2025-06-02
Accepted
2025-06-02 16:35:55
Documents
13
Period of Report
2025-06-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d17589d8k.htm   iXBRL 8-K 29677
2 EX-99.1 d17589dex991.htm EX-99.1 8603
  Complete submission text file 0001193125-25-133348.txt   158080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20250601.xsd EX-101.SCH 2870
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20250601_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20250601_pre.xml EX-101.PRE 11274
16 EXTRACTED XBRL INSTANCE DOCUMENT d17589d8k_htm.xml XML 3685
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 251015573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)